NEW YORK (GenomeWeb News) – KeyGene and Floragenex today said that they have agreed to end a legal dispute and have entered into a licensing agreement covering sequence-based genotyping technology.

KeyGene had filed the patent infringement suit against Floragenex last year in the US District Court for the District of Orgeon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.